USPTO serial 79367529
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles Ho
Charles Ho Barron & Young PLLC5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for industrial purposes; industrial chemicals; chemical reagents, other than for medical or veterinary purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleic acid for laboratory use; nucleic acid for laboratory use, namely, DNA, RNA and/or mRNA oligonucleotides, modified nucleosides and reagents for use in genetic research for nucleic acid synthesis, and chemical reagents for medical research use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; reagent paper, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; biochemical catalysts; cryogenic preparations in solid, liquid or gas state for use in chilling and freezing | ACTIVE | — |
| 005 | Pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations acting on the central nervous system; nucleic acid sequences and chemical reagents, namely, mRNA and mRNA capping reagents for pharmaceutical purposes and medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; immunostimulants; antiseptics; antivirals; cellular function activating agents for medical purposes; vaccine preparations; depuratives for the body; biocides; biological preparations for the treatment of cancer | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 9, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 20, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 19, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 20, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 19, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 19, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 2, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 2, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 2, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 13, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 13, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 21, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 17, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 17, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 17, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 19, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 19, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 4, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 25, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 20, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 19, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 13, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |